文献速递乳房整形与再造美容整形

局部氨甲环酸在初次乳房隆乳手术中的应用:短期与长期结局

Topical Tranexamic Acid in Primary Breast Augmentation Surgery: Short- and Long-term Outcomes.
PubMed 文献 · Aesthet Surg J · 2023-01-01

本研究为单术者病例系列,纳入2017年3月至2018年3月期间接受初次乳房隆乳手术并在假体置入前于假体腔隙局部喷洒氨甲环酸的患者288例,记录早期术后并发症及5年长期结局如包膜挛缩与修复手术,总体并发症率为2.8%,无术后出血或血肿形成,结论强调局部氨甲环酸在乳房隆乳中的安全性和潜在获益。

要点

  • 288例初次乳房隆乳患者术中假体腔隙局部喷洒氨甲环酸,5年总体并发症率2.8%。
  • 无患者出现术后出血或血肿形成。
  • 需再手术的并发症包括波纹征3例(1.0%)、腔隙修整2例(0.7%)、包膜挛缩1例(0.3%)和破裂1例(0.3%)。

核心结论

  • 本研究强调局部氨甲环酸在乳房隆乳中具有安全性和潜在获益,出血率与包膜挛缩率均较低。

研究设计与样本

  • 单术者病例系列,纳入2017年3月至2018年3月期间接受初次乳房隆乳手术并在假体置入前于假体腔隙局部喷洒氨甲环酸的全部患者288例。

主要发现

  • 288例患者5年总体并发症率为2.8%。
  • 无患者出现术后出血或血肿形成。
  • 1例患者出现血清肿,经超声引导下引流处理。
  • 需再手术的并发症包括波纹征3例(1.0%)、腔隙修整2例(0.7%)、包膜挛缩1例(0.3%)和破裂1例(0.3%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Breast augmentation mammaplasty (BAM) remains the most popular cosmetic procedure done worldwide. Bleeding in this procedure increases the chance of capsular contracture. Tranexamic acid (TXA), an antifibrinolytic, has been widely used by other surgical specialties to reduce bleeding. OBJECTIVES: We aimed to evaluate the use of TXA in BAM surgery. METHODS: This was a single-surgeon case series of all patients who underwent primary BAM from March 2017 to March 2018 and received topical TXA spray to the implant pocket before implant insertion. Early postoperative complications and long-term outcomes, such as capsular contracture and revisional surgery, were recorded and described. RESULTS: Two hundred and eighty-eight patients were included in the study with an overall complication rate of 2.8% over 5 years. No patients had postoperative bleeding or hematoma formation. One patient had a seroma, managed with ultrasound drainage. Complications requiring reoperation included rippling (3, 1.0%), pocket revision (2, 0.7%), capsule contracture (1, 0.3%) and rupture (1, 0.3%). CONCLUSIONS: This study highlights the safety and potential benefits of the use of topical TXA in breast augmentation, with low bleeding and capsular contracture rates.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Lonie S, Abesamis GM, Law J, et al. Topical Tranexamic Acid in Primary Breast Augmentation Surgery: Short- and Long-term Outcomes. Aesthet Surg J. 2023. PMID: 37427875. doi:10.1093/asj/sjad219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。